Beijing Enlight Media, Wanda Film and Alibaba Pictures are the three most valuable private film companies in China, leading the world’s most populous nation in its growth into the largest global film market, according to Hurun Report.
Enlight Media, based in the Chinese capital but listed on the Shenzhen Stock Exchange, tops the list with 39 billion yuan (US$5.6 billion/HK$43.5 billion) in market value. It was the producer of the 2012 comedy Lost in Thailand, the first Chinese movie to gross more than 1 billion yuan at the box office. The company also distributed Stephen Chow’s The Mermaid, the nation’s 2016 box office champion.
“China has grown into the second-largest film market in the world only after North America, and it’s likely to become the largest market, especially this year when China’s control of the coronavirus pandemic is more effective than the US,” said Hurun Report’s chairman and chief researcher Rupert Hoogewerf, adding that the first ranking of its kind in China is based on market valuation and funds raised by non-listed producers.
Get the latest insights and analysis from our Global Impact newsletter on the big stories originating in China.
The global coronavirus pandemic, which closed thousands of cinemas, restaurants and public amenities, and kept tens of millions of Chinese homebound, has decimated China’s film industry, causing first-quarter ticket sales to plunge 88 per cent to 2.238 billion yuan, according to the China Film Association. One in five cinemas surveyed by the association laid off staff at the end of March during the worst of the country’s Covid-19 outbreak, and the entire industry lost an estimated 30 billion yuan in ticket sales as of the second half of May, according to Alibaba Pictures’ data.
Now, as the first major global economy to emerge out of the coronavirus lockdown, China is slowly getting factories, restaurants, offices, shopping centres and cinemas back online.
Work returned to 71 per cent of cinemas in China as of August 12, albeit with social distancing in place and drastically reduced capacity, according to Maoyan Entertainment. That still puts the industry in better shape than other markets to regain its growth, which recorded up to 23 per cent in compound annual growth rate over the past decade, Hoogewerf said.
In second place of the value ranking is Wanda Film, a unit of tycoon Wang Jianlin’s Dalian Wanda Group, with 36 billion yuan in capitalisation. The Shenzhen-listed owner of the American cinema chain AMC Entertainment was the producer and distributor of the 2015 reality comedy Running Man, which grossed 434 million yuan. Wanda paid US$2.6 billion in 2012 for AMC.
Alibaba Pictures, a unit of this newspaper’s owner Alibaba Group Holding, is in third place with 26 billion yuan in value. Alibaba Pictures jointly produced Green Book in 2018, which took home three Academy Awards the following year.
The rest of the Hurun China Most Valuable Film Companies 2020 list comprises Dadi Cinema Line, Tencent and Alibaba invested Bona Film. Huayi Brothers Media, which produced the 2004 movie starring Hong Kong’s Andy Lau in A World Without Thieves, also made the list.
Maoyan Entertainment, which owns the largest online movie ticket sales platform in China, as well as Huace Film and TV and Hengdian Entertainment were also in the list. In 10th place is Beijing Culture, producer of the 2019 science fiction movie The Wandering Earth, which grossed US$700 million worldwide and was the third-biggest movie in China’s film history.
Beijing remains China’s movie hub, where eight of the 10 most valuable film companies have based their headquarters, while Huace Film and TV and Hengdian Entertainment are based in Zhejiang province.
Did you know that China supplies 40% of the world’s active pharmaceutical ingredients (API) for drug manufacturing? Learn what other ways local healthcare players are expanding their global footprint from the China Healthcare Report, brought to you by SCMP Research, and get a comprehensive industry review and insights on Covid-19 induced market shifts. Purchase now and get a 30% discount before 30 September 2020. You will also receive access to 6 closed-door webinars led by China healthcare’s most influential C-suite executives.
More from South China Morning Post: